| Coherus BioSciences, Inc., a commercial-stage biotherapeutics company, focuses on the biosimilar market worldwide. It markets UDENYCA, a long-acting granulocyte-colony stimulating factor, which stimulates production of granulocytes in order to promote the body's ability to fight infections. The company sells UDENYCA in the United States. Its clinical-stage product candidates include immunology, anti-tumor necrosis factor biosimilar candidates, CHS-1420 for adalimumab and CHS-0214 for etanercept, which has completed Phase III clinical programs; ophthalmology biosimilar candidates, CHS-3351 for ranibizumab and CHS-2020 for aflibercept that is in preclinical development; and CHS-131, small molecule therapeutic candidate and other metabolic conditions. Coherus BioSciences, Inc. has collaboration and license agreements with Daiichi Sankyo Company, Limited; Baxalta Incorporated; Baxalta US Inc.; Baxalta GmbH; and Selexis SA. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was founded in 2010 and is headquartered in Redwood City, California. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Viret Jean-Frederic | Chief Financial Officer | May 20 | Sale | 17.66 | 1,278 | 22,569 | 46,567 | May 22 04:30 PM | | Anicetti Vincent R | Chief Operating Officer | May 18 | Option Exercise | 2.50 | 2,500 | 6,251 | 51,056 | May 20 05:01 PM | | Anicetti Vincent R | Chief Operating Officer | May 18 | Sale | 17.17 | 3,093 | 53,107 | 48,556 | May 20 05:01 PM | | Anicetti Vincent R | Chief Operating Officer | Apr 20 | Sale | 17.00 | 5,150 | 87,550 | 47,846 | Apr 21 04:24 PM | | Anicetti Vincent R | Chief Operating Officer | Apr 17 | Option Exercise | 2.50 | 5,000 | 12,503 | 57,996 | Apr 21 04:24 PM | | Anicetti Vincent R | Chief Operating Officer | Apr 17 | Sale | 15.57 | 5,000 | 77,850 | 52,996 | Apr 21 04:24 PM | | Wahlstrom Mats | Director | Mar 03 | Sale | 20.12 | 118,066 | 2,375,409 | 200,000 | Mar 05 04:31 PM | | Viret Jean-Frederic | Chief Financial Officer | Feb 19 | Option Exercise | 10.05 | 3,159 | 31,748 | 50,000 | Feb 21 06:16 PM | | Viret Jean-Frederic | Chief Financial Officer | Feb 19 | Sale | 22.33 | 3,159 | 70,552 | 46,841 | Feb 21 06:16 PM | | Anicetti Vincent R | Chief Operating Officer | Feb 18 | Option Exercise | 7.60 | 5,000 | 38,001 | 60,496 | Feb 20 04:07 PM | | Anicetti Vincent R | Chief Operating Officer | Feb 18 | Sale | 21.64 | 10,000 | 216,390 | 52,996 | Feb 20 04:07 PM | | Anicetti Vincent R | Chief Operating Officer | Jan 17 | Option Exercise | 7.60 | 5,000 | 38,001 | 65,496 | Jan 22 04:06 PM | | Anicetti Vincent R | Chief Operating Officer | Jan 17 | Sale | 19.59 | 10,000 | 195,931 | 57,996 | Jan 22 04:06 PM | | Viret Jean-Frederic | Chief Financial Officer | Jan 15 | Option Exercise | 10.05 | 6,318 | 63,496 | 53,159 | Jan 17 04:11 PM | | Viret Jean-Frederic | Chief Financial Officer | Jan 15 | Sale | 19.85 | 6,318 | 125,424 | 46,841 | Jan 17 04:11 PM | | HEALY JAMES | Director | Jan 12 | Option Exercise | 12.37 | 20,000 | 247,400 | 70,086 | Jan 13 04:45 PM | | HEALY JAMES | Director | Jan 09 | Option Exercise | 5.02 | 49,994 | 251,000 | 50,086 | Jan 13 04:45 PM | | Anicetti Vincent R | Chief Operating Officer | Dec 16 | Option Exercise | 2.50 | 2,500 | 6,251 | 21,826 | Dec 18 04:28 PM | | Anicetti Vincent R | Chief Operating Officer | Dec 16 | Sale | 18.69 | 2,500 | 46,725 | 19,326 | Dec 18 04:28 PM | | Lanfear Dennis M | President & CEO | Nov 21 | Sale | 18.56 | 12,500 | 231,960 | 446,684 | Nov 25 04:03 PM | | Viret Jean-Frederic | Chief Financial Officer | Nov 20 | Option Exercise | 10.05 | 3,159 | 31,748 | 6,462 | Nov 22 04:09 PM | | Lanfear Dennis M | President & CEO | Nov 20 | Sale | 18.00 | 825,000 | 14,850,000 | 459,184 | Nov 22 06:56 PM | | Viret Jean-Frederic | Chief Financial Officer | Nov 20 | Sale | 19.59 | 3,159 | 61,872 | 3,303 | Nov 22 04:09 PM | | Viret Jean-Frederic | Chief Financial Officer | Nov 18 | Sale | 18.88 | 3,112 | 58,757 | 3,303 | Nov 20 04:22 PM | | Anicetti Vincent R | Chief Operating Officer | Nov 14 | Option Exercise | 2.50 | 2,500 | 6,251 | 21,810 | Nov 18 04:10 PM | | Anicetti Vincent R | Chief Operating Officer | Nov 14 | Sale | 19.26 | 2,500 | 48,150 | 19,310 | Nov 18 04:10 PM | | Viret Jean-Frederic | Chief Financial Officer | Oct 18 | Sale | 19.02 | 1,388 | 26,400 | 6,385 | Oct 22 04:06 PM | | Viret Jean-Frederic | Chief Financial Officer | Oct 16 | Option Exercise | 10.05 | 3,159 | 31,748 | 10,932 | Oct 18 04:05 PM | | Viret Jean-Frederic | Chief Financial Officer | Oct 16 | Sale | 19.00 | 3,159 | 60,021 | 7,773 | Oct 18 04:05 PM | | Anicetti Vincent R | Chief Operating Officer | Oct 14 | Option Exercise | 2.50 | 2,500 | 6,251 | 21,810 | Oct 16 04:08 PM | | Anicetti Vincent R | Chief Operating Officer | Oct 14 | Sale | 18.40 | 2,500 | 46,000 | 19,310 | Oct 16 04:08 PM | | Viret Jean-Frederic | Chief Financial Officer | Sep 23 | Sale | 21.78 | 740 | 16,117 | 7,773 | Sep 25 04:05 PM | | Viret Jean-Frederic | Chief Financial Officer | Sep 18 | Option Exercise | 10.05 | 3,159 | 31,748 | 11,672 | Sep 20 04:05 PM | | Viret Jean-Frederic | Chief Financial Officer | Sep 18 | Sale | 20.44 | 3,159 | 64,560 | 8,513 | Sep 20 04:05 PM | | Anicetti Vincent R | Chief Operating Officer | Sep 16 | Option Exercise | 2.50 | 2,500 | 6,251 | 21,810 | Sep 18 04:05 PM | | Anicetti Vincent R | Chief Operating Officer | Sep 16 | Sale | 20.03 | 2,500 | 50,075 | 19,310 | Sep 18 04:05 PM | | Viret Jean-Frederic | Chief Financial Officer | Aug 21 | Option Exercise | 10.05 | 6,318 | 63,496 | 14,831 | Aug 23 04:05 PM | | Viret Jean-Frederic | Chief Financial Officer | Aug 21 | Sale | 21.71 | 6,318 | 137,154 | 8,513 | Aug 23 04:05 PM | | Viret Jean-Frederic | Chief Financial Officer | Aug 19 | Sale | 19.04 | 3,000 | 57,120 | 8,513 | Aug 21 04:05 PM | | Anicetti Vincent R | Chief Operating Officer | Aug 14 | Option Exercise | 2.50 | 2,500 | 6,251 | 21,810 | Aug 16 04:07 PM | | Anicetti Vincent R | Chief Operating Officer | Aug 14 | Sale | 19.00 | 2,500 | 47,500 | 19,310 | Aug 16 04:07 PM | | Anicetti Vincent R | Chief Operating Officer | Jul 15 | Option Exercise | 2.50 | 2,500 | 6,251 | 21,810 | Jul 17 04:05 PM | | Anicetti Vincent R | Chief Operating Officer | Jul 15 | Sale | 19.20 | 2,500 | 48,000 | 19,310 | Jul 17 04:05 PM | | HEALY JAMES | Director | Jul 02 | Sale | 22.61 | 160,000 | 3,617,600 | 1,933,221 | Jul 02 06:57 PM | | HEALY JAMES | Director | Jun 28 | Sale | 22.05 | 200,000 | 4,410,000 | 2,093,221 | Jul 02 06:57 PM | | HEALY JAMES | Director | Jun 20 | Sale | 21.37 | 317,130 | 6,777,068 | 2,293,221 | Jun 24 06:30 PM | | Viret Jean-Frederic | Chief Financial Officer | Jun 19 | Option Exercise | 10.05 | 3,159 | 31,748 | 14,672 | Jun 20 04:05 PM | | Viret Jean-Frederic | Chief Financial Officer | Jun 19 | Sale | 20.28 | 3,826 | 77,587 | 11,513 | Jun 20 04:05 PM | | Viret Jean-Frederic | Chief Financial Officer | Jun 18 | Sale | 19.31 | 3,000 | 57,926 | 12,180 | Jun 20 04:05 PM |
|
